Nidhi Batra

Learn More
PURPOSE While effective targeted therapies exist for estrogen receptor-positive and HER2-positive breast cancer, no such effective therapies exist for triple-negative breast cancer (TNBC); thus, it is clear that additional targets for radiosensitization and treatment are critically needed. EXPERIMENTAL DESIGN Expression microarrays, qRT-PCR, and Western(More)
Purpose: While effective targeted therapies exist for estrogen receptor–positive and HER2-positive breast cancer, no such effective therapies exist for triple-negative breast cancer (TNBC); thus, it is clear that additional targets for radiosensitization and treatment are critically needed. Experimental Design: Expression microarrays, qRT-PCR, and Western(More)
The Editor, Marc Lippman, and Associate Editors: Stephen P. Ethier, Kevin S. Hughes, Alberto Montero, Steven A. Narod, and Ben H. Park would like to acknowledge the valuable contributions of the reviewers to the journal. We fully understand the burden and effort that are involved in the reviews. We rely on your expertise to maintain the standards of(More)
  • 1